Comment Submissions - Carcinogen Identification Committee Meeting Announcement and Hazard Identification Document Availability

Comment by: 
U.S. Food and Drug Administration
Received on: 
11/14/2022 - 3:32pm
Comment: 
FDA submission to docket. Please contact Intergovernmental Affairs staff with any questions. IGA@fda.hhs.gov